Organization
Nebraska Cancer Specialists - Midwest Cancer Center
1 abstract
Abstract
A randomized, open-label, phase II study of high-dose interleukin 2 vs high-dose interleukin 2 plus entinostat in renal cell carcinoma.Org: University at Buffalo Jacobs School of Medicine and Biomedical Sciences, USC Norris Comprehensive Cancer Center, Keck Medicine of USC, Nebraska Cancer Specialists - Midwest Cancer Center, Rush University Medical Center,